Inhibition of human NK cell-mediated killing by CD1 molecules

被引:27
作者
Carbone, E
Terrazzano, G
Melián, A
Zanzi, D
Moretta, L
Porcelli, S
Kärre, K
Zappacosta, S
机构
[1] Ctr Microbiol & Tumor Biol, Karolinska Inst, S-17177 Stockholm, Sweden
[2] Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, Cattedra Immunol, Naples, Italy
[3] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Lymphocyte Biol Sect, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Boston, MA 02115 USA
[5] Univ Genoa, Ist Nazl Ric Canc, Genoa, Italy
[6] Univ Genoa, Dipartimento Med Sperimentale, Genoa, Italy
关键词
D O I
10.4049/jimmunol.164.12.6130
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
It is now well established that NK cells recognize classical and nonclassical MHC class I molecules and that such recognition typically results in the inhibition of target cell lysis, Given the known structural similarities between MHC class I and non-MHC-encoded CD1 molecules, we investigated the possibility that human CD1a, -b, and -c proteins might also function as specific target structures for NK cell receptors, Here we report that expression of CD1a, -b, or -c can partially inhibits target cell lysis by freshly isolated human NK cells and cultured NK lines. The inhibitory effects of CD1 molecules on NK cell could be shown upon expression of individual CD1 proteins in transfected NK-sensitive target cells, and these effects could be reversed by incubation of the target cells with mAbs specific for the expressed form of CD1, Inhibitory effects of CD1 expression on NK-mediated lysis could also be shown for cultured human dendritic cells, which represent a cell type that prominently expresses the various CD1 proteins in vivo. In addition, the bacterial glycolipid Ags known to be bound and presented by CD1 proteins could significantly augment the observed inhibitory effects on target cell lysis by NK cells.
引用
收藏
页码:6130 / 6137
页数:8
相关论文
共 23 条
  • [1] Beckman EM, 1996, J IMMUNOL, V157, P2795
  • [2] RECOGNITION OF A LIPID ANTIGEN BY CD1-RESTRICTED ALPHA-BETA(+) T-CELLS
    BEEKMAN, EM
    PORCELLI, SA
    MORITA, CT
    BEHAR, SM
    FURLONG, ST
    BRENNER, MB
    [J]. NATURE, 1994, 372 (6507) : 691 - 694
  • [3] TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide
    Braud, VM
    Allan, DSJ
    Wilson, D
    McMichael, AJ
    [J]. CURRENT BIOLOGY, 1998, 8 (01) : 1 - 10
  • [4] HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
    Braud, VM
    Allan, DSJ
    O'Callaghan, CA
    Söderström, K
    D'Andrea, A
    Ogg, GS
    Lazetic, S
    Young, NT
    Bell, JI
    Phillips, JH
    Lanier, LL
    McMichael, AJ
    [J]. NATURE, 1998, 391 (6669) : 795 - 799
  • [5] A new mechanism of NK cell cytotoxicity activation: The CD40-CD40 ligand interaction
    Carbone, E
    Ruggiero, G
    Terrazzano, G
    Palomba, C
    Manzo, C
    Fontana, S
    Spits, H
    Karre, K
    Zappacosta, S
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (12) : 2053 - 2060
  • [6] Carbone E, 1999, EUR J IMMUNOL, V29, P4022, DOI 10.1002/(SICI)1521-4141(199912)29:12<4022::AID-IMMU4022>3.3.CO
  • [7] 2-F
  • [8] Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1)
    Chambers, BJ
    Salcedo, M
    Ljunggren, HG
    [J]. IMMUNITY, 1996, 5 (04) : 311 - 317
  • [9] CHANG CS, 1999, J EXP MED, P189
  • [10] SELECTIVE REJECTION OF H-2-DEFICIENT LYMPHOMA VARIANTS SUGGESTS ALTERNATIVE IMMUNE DEFENSE STRATEGY
    KARRE, K
    LJUNGGREN, HG
    PIONTEK, G
    KIESSLING, R
    [J]. NATURE, 1986, 319 (6055) : 675 - 678